GradedHealth

Soy

Last reviewed October 2026 · Based on 25 studies

Bottom line

Soy protein lowers LDL cholesterol by a small amount, about 5 mg/dL in pooled trials, but the LDL effect was not statistically significant in one analysis of postmenopausal women. For hot flashes the evidence is mixed and limited, and a 270-woman trial found no benefit. People on thyroid medicine or with a history of breast cancer should check with a doctor before taking soy isoflavone supplements.

What it helps with

  • Lowers LDL cholesterol — Benefit, evidence grade C (Limited). Meta-analyses of RCTs show a small drop; downgraded for inconsistency (heterogeneity up to 99%; not significant in postmenopausal women) and for LDL being a surrogate marker.
  • Eases hot flashes — Mixed results, evidence grade C (Limited). Meta-analyses disagree and the Cochrane review found no conclusive effect; many trials small and at high risk of bias; downgraded for inconsistency.
  • Raises breast cancer risk — No effect, evidence grade B (Moderate). Large prospective cohort (over 300,000 women) with a dose-response meta-analysis; observational so capped at B; the cohort found no increase.

What it is

Soy foods are made from soybeans, such as soya milk and whole soybeans [1]. Trials test whole soy foods, soy protein and isoflavone extracts [1]. Isoflavones are plant compounds with estrogen-like effects [2].

What the research says

For LDL cholesterol, a 46-trial pooled analysis found soy protein lowered LDL by about 4.8 mg/dL, roughly 3 to 4 per cent [3]. A 35-trial analysis found a similar drop, larger in people with high cholesterol and with whole soy foods [1]. Isolated soy isoflavone supplements had no effect on the lipid profile in that analysis [1], and LDL was not significantly lower in a meta-analysis of postmenopausal women [4].

For hot flashes, a 2015 meta-analysis estimated isoflavones cut hot flashes by about 25% after the placebo effect was removed, but the effect is slow [5]. A 2016 analysis linked soy isoflavones to about 0.8 fewer hot flashes a day [6]. The 2013 Cochrane review found no conclusive evidence of benefit [2]. A 2025 meta-analysis of 12 studies found a small overall effect on menopause symptoms but no significant effect on hot flushes [7].

For breast cancer, a study of more than 300,000 Chinese women found moderate soy intake was not linked to higher risk [8].

Doses used in studies

LDL trials used a median of 25 g of soy protein a day for about six weeks [3]. Hot flash trials used 84 to 126 mg of soy germ isoflavones a day [9], 10 to 60 mg of isoflavones a day in a soy drink [10], and 40 g of soy flour a day for six months [11]. These are trial doses, not recommendations.

Safety and interactions

Side effects: the Cochrane review found no evidence of womb or vaginal stimulation, or other adverse effects, in trials lasting up to two years, but most trials were small [2]. Upper limits and toxic doses: the studies we read did not identify a toxic dose, and we found no upper intake limit to quote.

Thyroid: a 60-person trial found overt hypothyroidism in six people after a 16 mg daily soy phytoestrogen dose [12]. A small 12-woman study found a soy isoflavone supplement did not change levothyroxine absorption [13], and a review found any effect likely small [14]. Breast cancer: higher intake was not linked to breast cancer risk [8]. In women already diagnosed, pre-diagnosis intake was linked to a small survival gain after menopause, but the evidence is limited [15].

Pregnancy and breastfeeding: we found no trials of soy supplements in these groups. Kidney, liver and bleeding disorders were not addressed in the studies we read; ask a doctor if you have these conditions.

Caveats and open questions

Results between trials vary widely, with heterogeneity of 92 to 99% in one 2015 analysis [1]. Many menopause trials were small and at high risk of bias, and placebo groups improved by between 1% and 59% [2][6]. Several menopause products mix soy with other herbs, so their results do not show what soy alone does [16][17]. Mood: one trial found no effect on everyday mood [10], while a meta-analysis found a small drop in depression [18]. One 2023 meta-analysis of isoflavone supplements found lower triglycerides and slightly higher HDL in women under 65, with no LDL result in its abstract [19].

References

  1. Soya products and serum lipids: a meta-analysis of randomised controlled trials.. Br J Nutr, 2015.
  2. Phytoestrogens for menopausal vasomotor symptoms.. Cochrane Database Syst Rev, 2013.
  3. A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.. J Nutr, 2019.
  4. Effects of Soy Protein Containing of Isoflavones and Isoflavones Extract on Plasma Lipid Profile in Postmenopausal Women as a Potential Prevention Factor in Cardiovascular Diseases: Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Nutrients, 2021.
  5. Quantitative efficacy of soy isoflavones on menopausal hot flashes.. Br J Clin Pharmacol, 2015.
  6. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.. JAMA, 2016.
  7. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis.. PeerJ, 2025.
  8. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis.. Eur J Epidemiol, 2020.
  9. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.. Menopause, 2012.
  10. The effect of a randomized 12-week soy drink intervention on everyday mood in postmenopausal women.. Menopause, 2019.
  11. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.. Menopause, 2014.
  12. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study.. J Clin Endocrinol Metab, 2011.
  13. Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.. Drug Res (Stuttg), 2016.
  14. Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.. Endocr Pract, 2023.
  15. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.. Eur J Nutr, 2019.
  16. Assessing the combined effects of Black Cohosh, Soy Isoflavones, and SDG Lignans on menopausal symptoms: a randomized, double-blind, placebo-controlled clinical trial.. Eur J Nutr, 2025.
  17. Efficacy and Safety of a Standardized Soy and Hop Extract on Menopausal Symptoms: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. J Altern Complement Med, 2021.
  18. The effect of soy isoflavones given to women in the climacteric period on menopausal symptoms and quality of life: Systematic review and meta-analysis of randomized controlled trials.. Explore (NY), 2024.
  19. Effect of Isoflavones on Blood Lipid Alterations in Postmenopausal Females: A Systematic Review and Meta-Analysis of Randomized Trials.. Adv Nutr, 2023.